Abstract
␤APP processing and A␤ generation

It is well established that the abnormal generation and deposition of amyloid ␤ peptides (A␤) is a pathologic hallmark of AD. A␤ is generated by two sequential proteolytic cleavage steps from the ␤-amyloid precursor protein (␤APP) [Reviewed in
. ␤APP is initially cleaved by ␤-secretase, which has been identified as a ␤-site APP-cleaving transmembrane aspartic protease (BACE) [4] , which has been suggested to occur in the endocytic pathway. This cleavage is followed by the subsequent intramembrane proteolysis of the membrane-bound C-terminal fragment (␤CTF, C99) catalyzed by the ␥-secretase complex, which has been suggested to occur at the plasma membrane, although the exact cellular location of either of the cleavage events is not clearly understood.
Importantly, the A␤ peptides produced by ␥-secretase cleavage are heterogeneous in size, ranging from 38 to 43 amino acids, with the highly amyloidgenic 42 amino acid peptide suggested to be the most pathogenic [5] . These A␤ peptides can exist as monomers, oligomers or as amyloid fibrils [5] . Recent evidence suggests that the oligomeric form of these A␤ peptides may be the key form responsible for the cognitive problems of people with AD [5, 6] 10] . These four transmembrane proteins are presumed to be indispensable for ␥-secretase activity, because their co-expression enables reconstitution of the ␥-secretase activity [10] [11] [12] [13] [14] , while the absence of even one results in the absence of ␥-secretase activity and defects in the expression and/or maturation of the remaining partners [10, 11] . NCT, an integral membrane protein, has been reported to bind tightly to ␤APP-C99 and recruit it into the ␥-secretase complex [15] . Conformation changes in and/or N-linked glycosylation of NCT appears to play a prominent role in modulating ␥-secretase activity [16] [17] [18] [19] . Various APH-1 variants are believed to stabilize presenilin within the ␥-secretase complex [20] , while PEN-2 appears necessary for the endoproteolysis of presenilin, a step essential for the activity of the ␥-secretase complex [21, 22] . In addition to the processing of ␤APP, the ␥-secretase complex facilitates the regulated intramembrane proteolysis of other select type I membrane proteins, such as Notch, CD44 and E-cadherin, which play diverse physiological roles in multiple cell types and tissue [1] .
Cholesterol
There is growing evidence that cholesterol is linked to the development of AD [Reviewed in 23, 24] . Clearly there exists a relationship between AD and hypercholesterolaemia, in addition to coronary artery disease and hypertension [25] [26] [27] . Various experimental and clinical findings also strongly suggest that brain vascular and hemodynamic alternations may play an important role in the progression of AD [28] [29] [30] . In addition, the regulation of cholesterol homeostasis appears to also be perturbed, as the ⑀4 allele of ApoE, a major apolipoprotein in the brain, has been identified as important risk factors for AD [31] [32] [33] [34] . [36] In AD, the [37, 38] . In vivo studies have demonstrated that high cholesterol diets can increase A␤ levels in rabbits and in an AD mouse model [39] . While in vitro studies indicate that increased cellular cholesterol levels result in the increased production of A␤ peptides [40, 41] . In addition, cholesterol depletion also inhibits A␤ generation in hippocampal neurons [41] and increases ␥-secretase activity in cultured cells [42, 43] . Although these studies reveal that cellular cholesterol levels can modulate ␤APP processing, the exact mechanism by which this occurs remains unclear. To understand the relationship between cellular cholesterol levels and cellular ␤APP processing and A␤ production, we must discuss the distribution of membrane cholesterol and membrane rafts. [48, 49] . In this regard, membrane rafts are believed to play a central role in regulating several cellular processes, such as membrane sorting, trafficking and signal transduction [45, 47] . [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] . In addition to the ␥-secretase components, it has also been reported that ␤-secretase localizes in membrane rafts and that cholesterol depletion abrogates this localization [49, 50] . Ehehalt et al. [49] [31] . [63] [64] [65] [66] . Statins efficiently inhibit the rate-limiting enzyme, HMG CoA reductase, in the cholesterol biosynthetic pathway responsible for the production of non-sterol isoprenoids, notably farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), ubiquinone and dolichol, in addition to cholesterol [67] . Statins also effect intracellular cholesterol distribution, gene expression and proteasome activity [68] . Although there have been initial reports that treatment with cholesterol synthesis inhibitors can lower the A␤ levels in guinea pig and in the AD mouse [40, 68] , recent findings suggest that the lowering of A␤ levels by statins may not be so clear [69, 70] . Statins are believed to exert their effects by manipulating cholesterol and isoprenoid levels intracellularly leading to altered ␤APP processing and membrane signaling. Statin treatment has been shown to decrease the association of the active form of the ␥-secretase complex with membrane rafts [59] . Whether this effect is due to statin's reduction in cholesterol biosynthesis or a reduction in isoprenylation, or the more likely scenario, in which it is a complex combination of both, remains to be clearly elucidated [Reviewed in 71, 72] . It has also been suggested that statin-treatment-induced inhibition of isoprenylation results in a reduction in membrane raft clustering involved in ␤APP processing and A␤ generation [73] .
Membrane rafts
Fig. 1 Schematic diagram of lipid mediated dynamic association of ␥-secretase complex with its substrates. Assembly of presenilin (PS) with nicastrin (NCT) and APH-1 stabilizes PS, and the association of PEN2 activates PS to fragmented form [11]. Active ␥-secretase complex is targeted to membrane rafts by lipid modifications, such as myristoylation, palmitoylation or double isoprenylation. Amyloid precursor protein (␤APP) is mostly cleaved by ␣-secretase in non-raft domain to generate APPs␣ and ␣CTF, but some part of ␤APP in the membrane raft is cleaved at the beta site by ␤-secretase, which resides in cholesterol rich membrane raft, to generate APPs␤ and ␤CTF. After the ␣-or ␤-cleavage, NCT serves as a receptor for the ␥-secretase substrates. Accordingly, the ␤CTF (C99) is cleaved at gamma site by ␥-secretase in the raft domain to generate pathogenic form of A␤ peptides. C-terminal peptide is further cleaved at or ⑀ site by ␥-secretase to generate amyloid intracellular domain (AICD) peptide. In the non-raft domain, ␣CTF (C83) is further cleaved by
Statins
Several epidemiological studies have suggested that the use of 3-hydroxy-3-methylglutaryl-CoA-reductase inhibitors ('statins') to treat hypercholesterolaemia may reduce the risk of dementia
The clinical relevance of these findings is questionable, as it has been shown that at clinical dosages, only low statin concentrations are detected in the cerebrospinal fluid, and at such concentrations, although cholesterol biosynthesis may be reduced, it appears highly unlikely that isoprenoid synthesis is inhibited in the CNS [74] [75] [76] . Therefore, there may be other mechanisms underlying the clinical benefit of statin therapy [77] . It [73, [80] [81] [82] . Experimental evidence suggests that GTPases may play a significant role in AD pathogenesis [82, 83] . Ras has been implicated in the A␤ signaling cascade [80] . Neuronal Ras, Rac and RhoA appear to function in neuronal and synaptic plasticity [84] . Rab1B and Rab6 appear to function in the intracellular trafficking and processing of ␤APP [85] . Other GTPases have also been implicated in AD progression [86, 87] . Due to the fact that isoprenylation, in part, regulates both the functionality and the subcellular localization of these GTPases, it is likely that statin-induced inhibition of isoprenylation, as some experimental evidence suggests, would have complex ramifications on ␤APP trafficking and processing, A␤ formation and neuronal and synaptic plasticity [88] . We have shown that statin treatment decreases the association of the active form of the ␥-secretase complex with lipid rafts, and that this effect can be partially rescued through the addition of GGPP, suggesting that GGPP may in part regulate active ␥-secretase complex association with membrane rafts [59] . Consistent with this finding, and highlighting the importance of isoprenylation in AD progression, it has been suggested that two pools of A␤ exist and appear to function independently of each other, with the intracellular pool regulated by isoprenoids and the secreted pool regulated by cellular cholesterol levels [73] . 
ACAT inhibitors
